US/UK/Canada

Share

Pick a time period -
Tags ( Active)

Invitation to Observe Medical ASA's first half year 2024 presentation and Q&A

Oslo, August 19, 2024 - Observe Medical ("the Company" or "Observe Medical") will release its results for the first half year 2024 on Monday, 26 Augsut 2024. The presentation will be published on NewsWeb and the Company's website at 07:00 CET on the same day. The Company will host a presentation and Q&A session at 10:00 CET on the same day. Personal attendance is welcomed at Carnegie's offices at Aker Brygge, Fjordalleen 16. The session will also be streamed via webcast. To register and follow the presentation online, please copy and paste the following link into your browser, click

Jørgen Mann appointed permanent CEO of Observe Medical

Oslo, August 13, 2024 - Observe Medical ASA (the "Company" or "Observe Medical") announces the appointment of Jørgen Mann as its permanent Chief Executive Officer (“CEO”). Having served as interim CEO since February 2024, Mr. Mann has proven his leadership capabilities and deep insight into the Company's strategic operations. The board is fully confident in his ability to steer Observe Medical into its next phase, focusing on commercial milestones, growth, and innovation. His leadership is expected to be crucial as the Company moves forward with its ambitious goals in the healthcare

Observe Medical ASA – Participation in the Private Placement by Primary Insiders and their Close Associates

Oslo, 25 June 2024 Reference is made to the announcement made by Observe Medical ASA (the "Company" or "Observe Medical", and, together with its subsidiaries, the "Group", OSE ticker "OBSRV") yesterday, on 24 June 2024, regarding the successfully placed private placement of new shares in the Company to raise gross proceeds of NOK 22 million (the "Private Placement"). The Company is in this respect pleased to announce that members of the board of directors and members of the management or their close associates have been allocated shares in the Private Placement, as set out below:

Observe Medical ASA: Ex. Subsequent Offering today

OBSRV – EX. SUBSEQUENT OFFERING TODAY Issuer name: Observe Medical ASA Ex. date: 25 June 2024 Type of corporate action: Subsequent offering/repair issue Additional information: Reference is made to the stock exchange announcement published by Observe Medical ASA on 24 June 2024 with key information relating to the subsequent offering.   This information is published in accordance with the requirements of the Continuing Obligations.

Observe Medical ASA: Key information relating to subsequent offering _ repair issue

NOT FOR DISTRIBUTION, PUBLICATION OR RELEASE, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, JAPAN, HONG KONG, SOUTH AFRICA OR THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION, PUBLICATION OR RELEASE WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN. Oslo, 24 June 2024 Reference is made to the stock exchange announcement by Observe Medical ASA ("Observe Medical" or the "Company", OSE ticker: OBSVR) earlier today, regarding the placement of a private placement (the "Private

Observe Medical – CFO resignation

Oslo, March 21, 2024 - Observe Medical ASA (the "Company" or "Observe Medical") announces that Per Arne Nygård has resigned from his position as CFO in order to pursue opportunities outside of the Company. Johan Fagerli, the current Finance Manager, will assume the responsibilities of Interim CFO effective immediately. Mr. Fagerli has been with the Company since 2021 and brings extensive experience and a deep understanding of our financial operations, ensuring a smooth transition and continued strategic financial management. We look forward to Mr. Fagerli's leadership in his new role

Invitation to Observe Medical ASA second half and full year 2023 presentation and Q&A

Oslo, March 6, 2024 - Observe Medical ("the Company" or "Observe Medical") will release its results for the second half and full year 2023 on Wednesday, 13 March 2024. The presentation will be published on NewsWeb and the Company's website at 07:00 CET on the same day. The Company will host a presentation and Q&A session at 08:30 CET on the same day. Personal attendance is welcomed at Olav Vs gate 5, 0161 Oslo . The session will also be

Observe Medical – Organizational changes

Oslo, February 29, 2024 - Observe Medical ASA (the "Company" or "Observe Medical") announces today that Rune Nystad has decided to step down from his role as Chief Executive Officer (“CEO”) with immediate effect to embrace new challenges within the Company. Jørgen Mann, the current Chief Commercial Officer (“CCO”), will step in as the interim CEO. Mr. Mann’s leadership abilities and deep understanding of the Company's operations make him well-qualified to oversee the Company's strategy and day-to-day management during this period. Mr. Nystad will transition into the role as Chief

Observe Medical – First order to Germany

Oslo, February 28, 2024 - Observe Medical ("the Company" or "Observe Medical") has received the first order for its UnoMeter products from Siramo GmbH, following the strategic Letter of Intent (LOI) announced in December 2023. This order marks the expansion into the German market, a key territory for the distribution of the UnoMeter product range. The founders of Siramo GmbH are industry experts with a rich background from the former largest Convatec distributor in Germany for UnoMeter. Therefore, this initial order and our formalized agreement represents a significant step towards

There are no items matching the current filter
There are no more items matching the current filter
Back to top

Subscribe